N Saijo

Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line.

N. Saijo, Y. Fujiwara, K. Nishio, 1992, Biochemical and biophysical research communications.

Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines.

T. Mukohara, N. Saijo, M. Hirai, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Indirect‐response model for the time course of leukopenia with anticancer drugs

N. Saijo, K. Itoh, Y. Sasaki, 1998, Clinical pharmacology and therapeutics.

Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.

N. Saijo, Y. Fujiwara, K. Nishio, 1991, Cancer research.